1. Home
  2. MIAX vs ADMA Comparison

MIAX vs ADMA Comparison

Compare MIAX & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MIAX

Miami International Holdings Inc.

N/A

Current Price

$41.23

Market Cap

3.6B

Sector

Finance

ML Signal

N/A

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

N/A

Current Price

$15.88

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MIAX
ADMA
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
MIAX
ADMA
Price
$41.23
$15.88
Analyst Decision
Buy
Strong Buy
Analyst Count
6
2
Target Price
$48.00
$28.50
AVG Volume (30 Days)
1.7M
3.2M
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.60
Revenue
N/A
$42,219,783.00
Revenue This Year
N/A
$27.46
Revenue Next Year
$12.06
$21.11
P/E Ratio
N/A
$25.65
Revenue Growth
N/A
43.85
52 Week Low
$31.20
$13.76
52 Week High
$51.38
$25.67

Technical Indicators

Market Signals
Indicator
MIAX
ADMA
Relative Strength Index (RSI) 47.19 45.90
Support Level $38.77 $14.19
Resistance Level $42.95 $16.46
Average True Range (ATR) 1.73 0.87
MACD 0.13 0.05
Stochastic Oscillator 57.12 49.81

Price Performance

Historical Comparison
MIAX
ADMA

About MIAX Miami International Holdings Inc.

Miami International Holdings Inc is a technology-driven leader in building and operating regulated financial marketplaces across multiple asset classes and geographies. Its MIAX Exchange marketplaces are enabled by its in-house built, proprietary technology. It maintains a broad portfolio of U.S. exchange and clearing licenses, in both securities and futures. The company operates markets across a diverse number of asset classes including options and cash equities as well as futures and options on futures.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: